不同种族和族裔晚期乳腺癌的人群归因风险
该队列研究利用2005年1月至2018年6月乳腺影像监测联盟社区影像设施前瞻性收集的数据,纳入904615名40至74岁女性的3331740次年度或 biennial 筛查乳腺X线检查及1815例筛查后2年内诊断的晚期乳腺癌,评估临床危险因素的的人群归因风险比例(PARP)。结果显示,体重指数(BMI)的PARP在绝经后高于绝经前(30% vs 22%),乳腺密度的PARP在绝经前高于绝经后(37% vs 24%),而筛查间隔的PARP较小(2.1%-2.3%)。结论认为,为减少晚期乳腺癌诊断,一级预防应关注将超重和肥胖患者转为正常体重的干预措施。
要点
- BMI的PARP在绝经后女性为30%,绝经前为22%。
- 乳腺密度的PARP在绝经前女性为37%,绝经后为24%。
- 筛查间隔( biennial vs 年度)的PARP较小,为2.1%-2.3%。
核心结论
- 在常规筛查女性中, biennial 与年度筛查相比,归因于筛查间隔的晚期乳腺癌比例较小。
- 为减少晚期乳腺癌诊断,一级预防应关注将超重和肥胖患者转为正常体重的干预措施。
研究设计与样本
- 队列研究,使用2005年1月至2018年6月乳腺影像监测联盟社区乳腺影像设施前瞻性收集的数据。
- 纳入904615名40至74岁女性,共3331740次年度(既往筛查间隔11-18个月)或 biennial(既往筛查间隔19-30个月)筛查乳腺X线检查, associated with 1815例筛查后2年内诊断的晚期乳腺癌。
- 数据分析于2022年9月至2023年8月进行。
主要发现
- BMI的PARP在绝经后女性为30%,绝经前女性为22%。
- BMI的PARP在绝经后黑人女性为38.6%(95% CI,32.0%-44.8%),绝经后西班牙裔/拉丁裔女性为31.8%(95% CI,25.3%-38.0%),绝经前黑人女性为30.3%(95% CI,17.7%-42.0%)。
- 超重/肥胖的总体患病率在绝经前黑人女性为84.4%,绝经后黑人女性为85.1%,西班牙裔/拉丁裔女性为72.4%。
- 乳腺密度的PARP在绝经前女性为37%,绝经后女性为24%;在绝经前亚裔或太平洋岛民女性为46.6%(95% CI,37.9%-54.4%),绝经前白人女性为39.8%(95% CI,31.7%-47.3%)。
- 乳腺癌家族史的PARP为5%-8%,良性乳腺活检史的PARP为7%-12%,筛查间隔的PARP为2.1%-2.3%。
关键数值与推荐
- 晚期乳腺癌定义为预后病理分期IIA期或更高。
- 暴露因素包括:乳腺不均匀致密或极度致密、一级亲属乳腺癌家族史、超重/肥胖(BMI >25.0)、良性乳腺活检史、筛查间隔( biennial vs 年度),按绝经状态和种族/族裔分层。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Advanced-stage breast cancer rates vary by race and ethnicity, with Black women having a 2-fold higher rate than White women among regular screeners. Clinical risk factors that explain a large proportion of advanced breast cancers by race and ethnicity are unknown. OBJECTIVE: To evaluate the population attributable risk proportions (PARPs) for advanced-stage breast cancer (prognostic pathologic stage IIA or higher) associated with clinical risk factors among routinely screened premenopausal and postmenopausal women by race and ethnicity. DESIGN, SETTING, AND PARTICIPANTS: This cohort study used data collected prospectively from Breast Cancer Surveillance Consortium community-based breast imaging facilities from January 2005 to June 2018. Participants were women aged 40 to 74 years undergoing 3 331 740 annual (prior screening within 11-18 months) or biennial (prior screening within 19-30 months) screening mammograms associated with 1815 advanced breast cancers diagnosed within 2 years of screening examinations. Data analysis was performed from September 2022 to August 2023. EXPOSURES: Heterogeneously or extremely dense breasts, first-degree family history of breast cancer, overweight/obesity (body mass index >25.0), history of benign breast biopsy, and screening interval (biennial vs annual) stratified by menopausal status and race and ethnicity (Asian or Pacific Islander, Black, Hispanic/Latinx, White, other/multiracial). MAIN OUTCOMES AND MEASURES: PARPs for advanced breast cancer. RESULTS: Among 904 615 women, median (IQR) age was 57 (50-64) years. Of the 3 331 740 annual or biennial screening mammograms, 10.8% were for Asian or Pacific Islander women; 9.5% were for Black women; 5.3% were for Hispanic/Latinx women; 72.0% were for White women; and 2.0% were for women of other races and ethnicities, including those who were Alaska Native, American Indian, 2 or more reported races, or other. Body mass index PARPs were larger for postmenopausal vs premenopausal women (30% vs 22%) and highest for postmenopausal Black (38.6%; 95% CI, 32.0%-44.8%) and Hispanic/Latinx women (31.8%; 95% CI, 25.3%-38.0%) and premenopausal Black women (30.3%; 95% CI, 17.7%-42.0%), with overall prevalence of having overweight/obesity highest in premenopausal Black (84.4%) and postmenopausal Black (85.1%) and Hispanic/Latinx women (72.4%). Breast density PARPs were larger for premenopausal vs postmenopausal women (37% vs 24%, respectively) and highest among premenopausal Asian or Pacific Islander (46.6%; 95% CI, 37.9%-54.4%) and White women (39.8%; 95% CI, 31.7%-47.3%) whose prevalence of dense breasts was high (62%-79%). For premenopausal and postmenopausal women, PARPs were small for family history of breast cancer (5%-8%), history of breast biopsy (7%-12%), and screening interval (2.1%-2.3%). CONCLUSIONS AND RELEVANCE: In this cohort study among routinely screened women, the proportion of advanced breast cancers attributed to biennial vs annual screening was small. To reduce the number of advanced breast cancer diagnoses, primary prevention should focus on interventions that shift patients with overweight and obesity to normal weight.
引用
- Kerlikowske K, Chen S, Bissell MCS, et al. Population Attributable Risk of Advanced-Stage Breast Cancer by Race and Ethnicity. JAMA Oncol. 2024. PMID: 38060241. doi:10.1001/jamaoncol.2023.5242
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。